DPP-4 inhibitors are a class of oral antihyperglycemic agents for treatment of type 2 diabetes.4 The effects of DPP-4 on lipid profiles in patients with type 2 diabetes have been widely investigated. This evidence concerns the gene DPP4 and type 2 diabetes mellitus.